HR 5575 · 118th Congress 2023โ€“2025, ended

Safe Medicine Act

Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 19, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to increase the domestic production of essential medicines, medical countermeasures, and critical inputs.

If the Food and Drug Administration determines that a drug or active pharmaceutical ingredient is manufactured in a country that may be producing contaminated drugs or ingredients due to systemic manufacturing-related problems, the labeling for that drug or ingredient must have a boxed warning about the potential for contamination.

For government procurement purposes, the President's authority to waive certain purchasing requirements that discriminate against foreign products may not be used to waive any preferences for goods that are essential medicines, medical countermeasures, or critical inputs.

Cosponsors

Members who signed on, in the order they did.

No cosponsors are on file for this measure.

Committees 4

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Sep 19, 2023
Health Subcommittee
Referred Sep 22, 2023
HouseArmed Services Committee
Referred Sep 19, 2023
HouseVeterans' Affairs Committee
Referred Sep 19, 2023
Health Subcommittee
Referred Sep 28, 2023
HouseWays and Means Committee
Referred Sep 19, 2023
Trade Subcommittee
Referred Dec 17, 2024
Health Subcommittee
Referred Dec 17, 2024

Actions 6

Everything that happened, newest first.

  1. Dec 17, 2024Referred to the Subcommittee on Trade.
  2. Dec 17, 2024Referred to the Subcommittee on Health.
  3. Sep 28, 2023Referred to the Subcommittee on Health.
  4. Sep 22, 2023Referred to the Subcommittee on Health.
  5. Sep 19, 2023Introduced in House

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8 The single subject of this legislation is: A bill to direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination.

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 151, September 19, 2023, page H4409.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 5003Safe Medicine ActReintroduction ofSep 9, 2021

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.
Short Title(s) as Introduced
Safe Medicine Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Sep 19, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.